In this Review:
Chemotherapy regimens compared in advanced NSCLC
Adjuvant chemotherapy ± Bev in resected NSCLC
Genomic architecture and spectra of EGFR mutant NSCLC
Stopping smoking lowers mortality in low-dose CT screening programmes
Updated CheckMate 017 data: nivolumab vs docetaxel
Safety, efficacy of nivolumab PD-L1+/- tumours
Safety, efficacy of nivolumab and ipilimumab in NSCLC
Atezolizumab + platinum chemotherapy in advanced NSCLC
Mechanisms of resistance to osimertinib in EGFR mutant NSCLC
Please login below to download this issue (PDF)